These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 32907497)

  • 1. Developing Bioinspired Three-Dimensional Models of Brain Cancer to Evaluate Tumor-Homing Neural Stem Cell Therapy.
    Carey-Ewend AG; Hagler SB; Bomba HN; Goetz MJ; Bago JR; Hingtgen SD
    Tissue Eng Part A; 2021 Jul; 27(13-14):857-866. PubMed ID: 32907497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing Bioinspired Three-Dimensional Models of Brain Cancer to Evaluate Tumor-Homing Neural Stem Cell Therapy.
    Carey-Ewend AG; Hagler SB; Bomba HN; Goetz MJ; Bago JR; Hingtgen SD
    Tissue Eng Part A; 2020 Oct; ():. PubMed ID: 33085922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-homing cytotoxic human induced neural stem cells for cancer therapy.
    Bagó JR; Okolie O; Dumitru R; Ewend MG; Parker JS; Werff RV; Underhill TM; Schmid RS; Miller CR; Hingtgen SD
    Sci Transl Med; 2017 Feb; 9(375):. PubMed ID: 28148846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of composite scaffold degradation rate on neural stem cell persistence in the glioblastoma surgical resection cavity.
    Moore KM; Graham-Gurysh EG; Bomba HN; Murthy AB; Bachelder EM; Hingtgen SD; Ainslie KM
    Mater Sci Eng C Mater Biol Appl; 2020 Jun; 111():110846. PubMed ID: 32279815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing Implantable Scaffolds to Enhance Neural Stem Cell Therapy for Post-Operative Glioblastoma.
    Sheets KT; Ewend MG; Mohiti-Asli M; Tuin SA; Loboa EG; Aboody KS; Hingtgen SD
    Mol Ther; 2020 Apr; 28(4):1056-1067. PubMed ID: 32109370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumoricidal stem cell therapy enables killing in novel hybrid models of heterogeneous glioblastoma.
    Satterlee AB; Dunn DE; Lo DC; Khagi S; Hingtgen S
    Neuro Oncol; 2019 Dec; 21(12):1552-1564. PubMed ID: 31420675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mathematical modeling of therapeutic neural stem cell migration in mouse brain with and without brain tumors.
    Gomez J; Holmes N; Hansen A; Adhikarla V; Gutova M; Rockne RC; Cho H
    Math Biosci Eng; 2022 Jan; 19(3):2592-2615. PubMed ID: 35240798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Neural Stem Cell Biodistribution and Predicted Tumor Coverage by a Diffusible Therapeutic in a Mouse Glioma Model.
    Barish ME; Herrmann K; Tang Y; Argalian Herculian S; Metz M; Aramburo S; Tirughana R; Gutova M; Annala A; Moats RA; Goldstein L; Rockne RC; Gutierrez J; Brown CE; Ghoda L; Aboody KS
    Stem Cells Transl Med; 2017 Jun; 6(6):1522-1532. PubMed ID: 28481046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic modulation of nasal epithelium augments neural stem cell targeting of glioblastoma.
    Spencer D; Yu D; Morshed RA; Li G; Pituch KC; Gao DX; Bertolino N; Procissi D; Lesniak MS; Balyasnikova IV
    Theranostics; 2019; 9(7):2071-2083. PubMed ID: 31037157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron labeling and pre-clinical MRI visualization of therapeutic human neural stem cells in a murine glioma model.
    Thu MS; Najbauer J; Kendall SE; Harutyunyan I; Sangalang N; Gutova M; Metz MZ; Garcia E; Frank RT; Kim SU; Moats RA; Aboody KS
    PLoS One; 2009 Sep; 4(9):e7218. PubMed ID: 19787043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural stem cells producing an inducible and soluble form of Gas1 target and inhibit intracranial glioma growth.
    López-Ornelas A; Vergara P; Segovia J
    Cytotherapy; 2014 Jul; 16(7):1011-23. PubMed ID: 24529556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation and Profiling of Tumor-Homing Induced Neural Stem Cells from the Skin of Cancer Patients.
    Buckley A; Hagler SB; Lettry V; Bagó JR; Maingi SM; Khagi S; Ewend MG; Miller CR; Hingtgen SD
    Mol Ther; 2020 Jul; 28(7):1614-1627. PubMed ID: 32402245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A preclinical evaluation of neural stem cell-based cell carrier for targeted antiglioma oncolytic virotherapy.
    Ahmed AU; Thaci B; Tobias AL; Auffinger B; Zhang L; Cheng Y; Kim CK; Yunis C; Han Y; Alexiades NG; Fan X; Aboody KS; Lesniak MS
    J Natl Cancer Inst; 2013 Jul; 105(13):968-77. PubMed ID: 23821758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrospun nanofibrous scaffolds increase the efficacy of stem cell-mediated therapy of surgically resected glioblastoma.
    Bagó JR; Pegna GJ; Okolie O; Mohiti-Asli M; Loboa EG; Hingtgen SD
    Biomaterials; 2016 Jun; 90():116-25. PubMed ID: 27016620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-cavity stem cell therapy inhibits tumor progression in a novel murine model of medulloblastoma surgical resection.
    Okolie O; Irvin DM; Bago JR; Sheets K; Satterlee A; Carey-Ewend AG; Lettry V; Dumitru R; Elton S; Ewend MG; Miller CR; Hingtgen SD
    PLoS One; 2018; 13(7):e0198596. PubMed ID: 29990322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linc-NSC affects cell differentiation, apoptosis and proliferation in mouse neural stem cells and embryonic stem cells in vitro and in vivo.
    Guo L; Zou D; Qiu W; Fei F; Chen L; Chen W; Xiong H; Li X; Wang Y; Gao M; Zhu J; Zhang J; He Y; Gao M; Xu R
    Cell Mol Life Sci; 2024 Apr; 81(1):182. PubMed ID: 38615283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas.
    Kauer TM; Figueiredo JL; Hingtgen S; Shah K
    Nat Neurosci; 2011 Dec; 15(2):197-204. PubMed ID: 22197831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary neural stem/progenitor cells expressing endostatin or cytochrome P450 for gene therapy of glioblastoma.
    Lorico A; Mercapide J; Solodushko V; Alexeyev M; Fodstad O; Rappa G
    Cancer Gene Ther; 2008 Sep; 15(9):605-15. PubMed ID: 18421309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative Evaluation of Intraventricular Delivery of Therapeutic Neural Stem Cells to Orthotopic Glioma.
    Gutova M; Flores L; Adhikarla V; Tsaturyan L; Tirughana R; Aramburo S; Metz M; Gonzaga J; Annala A; Synold TW; Portnow J; Rockne RC; Aboody KS
    Front Oncol; 2019; 9():68. PubMed ID: 30838174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrin matrices enhance the transplant and efficacy of cytotoxic stem cell therapy for post-surgical cancer.
    Bagó JR; Pegna GJ; Okolie O; Hingtgen SD
    Biomaterials; 2016 Apr; 84():42-53. PubMed ID: 26803410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.